Association between coffee drinking and K-ras mutations in exocrine pancreatic cancer

被引:59
|
作者
Porta, M
Malats, N
Guarner, L
Carrato, A
Rifà, J
Salas, A
Corominas, JM
Andreu, M
Real, FX
机构
[1] Univ Autonoma Barcelona, Inst Municipal Invest Med, E-08003 Barcelona, Spain
[2] Hosp Gen Valle Hebron, Dept Gastroenterol, Barcelona, Spain
[3] Hosp Gen Elche, Dept Oncol, Alicante, Spain
[4] Hosp Son Dureta, Dept Oncol, Mallorca, Spain
[5] Hosp Mutua Terrassa, Dept Pathol, Barcelona, Spain
[6] Univ Autonoma Barcelona, Hosp Mar, Dept Pathol, E-08003 Barcelona, Spain
[7] Univ Autonoma Barcelona, Hosp Mar, Dept Gastroenterol, E-08003 Barcelona, Spain
关键词
D O I
10.1136/jech.53.11.702
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Study objective-To analyse the relation between coffee consumption and mutations in the K-ras gene in exocrine pancreatic cancer. Design-Case-case study. Consumption of coffee among cases with the activating mutation in the K-ras gene was compared with that of cases without the mutation. Setting and patients-All cases of pancreatic cancer newly diagnosed at five hospitals in Spain during three years were included in the PANKRAS II Study (n=185, of whom 121 whose tissue was available for molecular analysis are the object of the present report). Over 88% were personally interviewed in hospital. DNA was amplified from paraffin wax embedded tissues, and mutations in codon 12 of K-ras were detected by the artificial RFLP technique. Main results-Mutations were found in tumours from 94 of 121 patients (77.7%). Mutations were more common among regular coffee drinkers than among nonregular coffee drinkers (82.0% v 55.6%, p=0.018, n=107). The odds ratio adjusted by age, sex, smoking and alcohol drinking was 5.41 (95% CI 1.64, 17.78). The weekly intake of coffee was significantly higher among patients with a mutated tumour (mean of 14.5 cups/week v 8.8 among patients with a wild type tumour, p<0.05). With respect to non-regular coffee drinkers, the odds ratio of a mutated tumour adjusted by age, sex, smoking and alcohol drinking was 3.26 for drinkers of 2-7 cups/week, 5.77 for drinkers of 8-14 cups/week and 9.99 for drinkers of greater than or equal to 15 cups/week (p<0.01, test for trend). Conclusions-Pancreatic cancer cases without activating mutations in the K-ras gene had drank significantly less coffee than cases with a mutation, with a significant dose response relation: the less they drank, the less likely their tumours were to harbour a mutation. In exocrine pancreatic cancer the K-ras gene may be activated less often among non-regular coffee drinkers than among regular drinkers. Caffeine, other coffee compounds or other factors with which coffee drinking is associated may modulate K-ras activation.
引用
收藏
页码:702 / 709
页数:8
相关论文
共 50 条
  • [1] Occupational exposures and K-ras mutations in exocrine pancreatic cancer
    Porta, M
    Alguacil, J
    Malats, N
    Kauppinen, T
    Kogevinas, M
    Benavides, F
    Partanen, T
    Carrato, A
    Rifa, J
    Guarner, L
    EPIDEMIOLOGY, 2000, 11 (04) : S93 - S93
  • [2] Coffee and some organochlorine compounds (OC) are associated with K-ras mutations in exocrine pancreatic cancer (EPC)
    Porta, M.
    Lopez, T.
    Jariod, M.
    Malats, N.
    Alguacil, J.
    Grimalt, J.
    Real, F. X.
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2006, 21 : 129 - 130
  • [3] Food and nutrient intakes and K-ras mutations in exocrine pancreatic cancer
    Morales, Eva
    Porta, Miquel
    Vioque, Jesús
    Lopez, Tomàs
    Mendez, Michelle A.
    Pumarega, José
    Malats, Núria
    Crous-Bou, Marta
    Ngo, Joy
    Rifà, Juli
    Carrato, Alfredo
    Guarner, Luisa
    Corominas, Josep M.
    Real, Francisco X.
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2007, 61 (07) : 641 - 649
  • [4] Coffee, K-ras mutations and pancreatic cancer:: A heterogeneous aetiology or an artefact?
    Jacobsen, BK
    Heuch, I
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2000, 54 (09) : 654 - 655
  • [5] Coffee, pancreatic cancer, and K-ras mutations:: updating the research agenda
    Porta, M
    Malats, N
    Alguacil, J
    Ruiz, L
    Jariod, M
    Carrato, A
    Rifá, L
    Guarner, L
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2000, 54 (09) : 656 - 659
  • [6] K-ras mutations in pancreatic cancer
    Grady, M
    Gaut, A
    Liu, JR
    Zhang, YP
    Zhang, H
    Weydert, C
    Domann, F
    Oberley, L
    Cullen, J
    FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 : S440 - S440
  • [7] Lifetime history of tobacco consumption and K-ras mutations in exocrine pancreatic cancer
    Crous-Bou, Marta
    Porta, Miquel
    Lopez, Tomas
    Jariod, Manuel
    Malats, Nuria
    Alguacil, Juan
    Morales, Eva
    Fernandez, Esteve
    Corominas, Josep M.
    Carrato, Alfredo
    Guarner, Luisa
    Real, Francisco X.
    PANCREAS, 2007, 35 (02) : 135 - 141
  • [8] Serum concentrations of organochlorine compounds and K-ras mutations in exocrine pancreatic cancer
    Porta, M
    Malats, N
    Jariod, M
    Grimalt, JO
    Rifà, J
    Carrato, A
    Guarner, L
    Salas, A
    Santiago-Silva, M
    Corominas, JM
    Andreu, M
    Real, FX
    LANCET, 1999, 354 (9196): : 2125 - 2129
  • [9] Occupational exposure to organic solvents and K-ras mutations in exocrine pancreatic cancer
    Alguacil, J
    Porta, M
    Malats, N
    Kauppinen, T
    Kogevinas, M
    Benavides, FG
    Partanen, T
    Carrato, A
    CARCINOGENESIS, 2002, 23 (01) : 101 - 106
  • [10] Low correspondence between K-ras mutations in pancreatic cancer tissue and detection of K-ras mutations in circulating DNA
    Marchese, Rodolfo
    Muleti, Alessandra
    Pasqualetti, Patrizio
    Bucci, Barbara
    Stigliano, Antonio
    Brunetti, Ercole
    De Angelis, Monica
    Mazzoni, Gianluca
    Tocchi, Adriano
    Brozzetti, Stefania
    PANCREAS, 2006, 32 (02) : 171 - 177